💉AIST: Understanding the mechanism of action and drug resistance of hepatitis B therapeutic drug with the help of AIDS virus
– Modify the AIDS virus reverse transcriptase to resemble the hepatitis B virus reverse transcriptase –
point
- Analyze its three-dimensional structure by linking Entecavir with hepatitis B therapeutic drug to the modified AIDS virus reverse transcriptase
- Elucidate the mechanism by which entecavir binds to reverse transcriptase and the mechanism by which drug resistance develops
- Expect anticipated drug development acting on drug-resistant hepatitis B virus
This research result will be published online in the journal Scientific Reports on January 26, 2018 (UK time).
http://www.aist.go.jp/aist_j/press_release/pr2018/pr20180126/pr20180126.html